IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 49 filers reported holding IKENA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,728,711 | -34.0% | 5,018,178 | 0.0% | 3.36% | -17.9% |
| Q2 2023 | $32,919,248 | +90.1% | 5,018,178 | 0.0% | 4.10% | +74.8% |
| Q1 2023 | $17,312,714 | +29.7% | 5,018,178 | 0.0% | 2.34% | +45.8% |
| Q4 2022 | $13,348,353 | -25.1% | 5,018,178 | 0.0% | 1.61% | -18.2% |
| Q3 2022 | $17,815,000 | -19.9% | 5,018,178 | 0.0% | 1.97% | -47.1% |
| Q2 2022 | $22,231,000 | -27.4% | 5,018,178 | 0.0% | 3.72% | -4.0% |
| Q1 2022 | $30,611,000 | -51.4% | 5,018,178 | 0.0% | 3.87% | -33.0% |
| Q4 2021 | $62,928,000 | – | 5,018,178 | – | 5.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |